CN112206187B - Skin care compositions - Google Patents
Skin care compositions Download PDFInfo
- Publication number
- CN112206187B CN112206187B CN201910630710.5A CN201910630710A CN112206187B CN 112206187 B CN112206187 B CN 112206187B CN 201910630710 A CN201910630710 A CN 201910630710A CN 112206187 B CN112206187 B CN 112206187B
- Authority
- CN
- China
- Prior art keywords
- parts
- skin care
- skin
- care composition
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 110
- 229920001577 copolymer Polymers 0.000 claims abstract description 28
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 24
- 239000006166 lysate Substances 0.000 claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 18
- 230000004151 fermentation Effects 0.000 claims abstract description 18
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims description 48
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 39
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 34
- 238000010438 heat treatment Methods 0.000 claims description 32
- 238000002156 mixing Methods 0.000 claims description 32
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 claims description 23
- 244000179886 Moringa oleifera Species 0.000 claims description 23
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 23
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 23
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 23
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 23
- 235000010384 tocopherol Nutrition 0.000 claims description 23
- 229960001295 tocopherol Drugs 0.000 claims description 23
- 229930003799 tocopherol Natural products 0.000 claims description 23
- 239000011732 tocopherol Substances 0.000 claims description 23
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 23
- 229960003966 nicotinamide Drugs 0.000 claims description 20
- 235000005152 nicotinamide Nutrition 0.000 claims description 20
- 239000011570 nicotinamide Substances 0.000 claims description 20
- 230000002829 reductive effect Effects 0.000 claims description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 16
- 230000001804 emulsifying effect Effects 0.000 claims description 16
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 12
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 12
- 229960002216 methylparaben Drugs 0.000 claims description 12
- 241000235346 Schizosaccharomyces Species 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 238000003912 environmental pollution Methods 0.000 abstract description 12
- 241000220215 Moringa Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 122
- 230000000052 comparative effect Effects 0.000 description 57
- -1 PEG-100 distearate Chemical compound 0.000 description 21
- 239000003755 preservative agent Substances 0.000 description 14
- 239000003963 antioxidant agent Substances 0.000 description 13
- 239000003995 emulsifying agent Substances 0.000 description 13
- 239000003906 humectant Substances 0.000 description 13
- 230000003078 antioxidant effect Effects 0.000 description 12
- 230000009286 beneficial effect Effects 0.000 description 12
- 230000002335 preservative effect Effects 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000008439 repair process Effects 0.000 description 9
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 8
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 230000003266 anti-allergic effect Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 229930182478 glucoside Natural products 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 5
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 241000510672 Cuminum Species 0.000 description 4
- 235000007129 Cuminum cyminum Nutrition 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 241001634513 Pterospermum Species 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000003344 environmental pollutant Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229940087068 glyceryl caprylate Drugs 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 231100000719 pollutant Toxicity 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 229940068977 polysorbate 20 Drugs 0.000 description 4
- 235000010388 propyl gallate Nutrition 0.000 description 4
- 239000000473 propyl gallate Substances 0.000 description 4
- 229940075579 propyl gallate Drugs 0.000 description 4
- 229960003415 propylparaben Drugs 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- BVHIKUCXNBQDEM-JSNMRZPZSA-N (3s,4r,5s)-5-(4-hydroxy-3-methoxyphenyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]-4-(hydroxymethyl)oxolan-3-ol Chemical compound C1=C(O)C(OC)=CC(C[C@]2(O)[C@@H]([C@H](OC2)C=2C=C(OC)C(O)=CC=2)CO)=C1 BVHIKUCXNBQDEM-JSNMRZPZSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- YBVRFTBNIZWMSK-UHFFFAOYSA-N 2,2-dimethyl-1-phenylpropan-1-ol Chemical compound CC(C)(C)C(O)C1=CC=CC=C1 YBVRFTBNIZWMSK-UHFFFAOYSA-N 0.000 description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 3
- 241001530056 Athelia rolfsii Species 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- NYDZRKZVFLLTLO-UHFFFAOYSA-N Neoolivil Natural products C1=C(O)C(OC)=CC(C2C(C(CO)C(O2)C=2C=C(OC)C(O)=CC=2)CO)=C1 NYDZRKZVFLLTLO-UHFFFAOYSA-N 0.000 description 3
- BVHIKUCXNBQDEM-UHFFFAOYSA-N Olivil Natural products C1=C(O)C(OC)=CC(CC2(O)C(C(OC2)C=2C=C(OC)C(O)=CC=2)CO)=C1 BVHIKUCXNBQDEM-UHFFFAOYSA-N 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 108010020346 Polyglutamic Acid Proteins 0.000 description 3
- 239000004373 Pullulan Substances 0.000 description 3
- 229920001218 Pullulan Polymers 0.000 description 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 3
- 241001506047 Tremella Species 0.000 description 3
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 229960004365 benzoic acid Drugs 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940071160 cocoate Drugs 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229940049964 oleate Drugs 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 235000010241 potassium sorbate Nutrition 0.000 description 3
- 239000004302 potassium sorbate Substances 0.000 description 3
- 229940069338 potassium sorbate Drugs 0.000 description 3
- 235000019423 pullulan Nutrition 0.000 description 3
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 229960003885 sodium benzoate Drugs 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- CCLARULDIPFTCP-BOYHRMMASA-N (2r,3r,4r,5s)-heptane-1,2,3,4,5,6-hexol Chemical compound CC(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CCLARULDIPFTCP-BOYHRMMASA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical group COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000013462 Interleukin-12 Human genes 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011066 ex-situ storage Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 235000008113 selfheal Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037070 skin defense Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides a skin care composition comprising: VP/hexadecene copolymer, polyquaternium-7, moringa pterospiana seed extract, nicotinamide, and Dischizosaccharomyces cerevisiae fermentation product lysate. The skin care composition disclosed by the invention can resist environmental pollution, improves the self-repairing capability of skin and has a better skin repairing effect.
Description
Technical Field
The invention relates to the field of skin care products, and in particular relates to a skin care composition and application thereof.
Background
Modern people have fast pace of life, poor sleep, lack of skin maintenance, increasingly serious environmental pollution, ultraviolet rays, radioactive rays, computer electric appliance radiation, smoking and drinking, excessive exercise, tension pressure, excessive intake of processed food and grease which are eaten too much, and the like, which cause a plurality of skin problems.
With the continuous bad environment and the continuous increase of human pollution sources, the skin becomes more sensitive due to the bad environment. Human skin is a barrier between the body and the environment, and is the organ which has the longest contact time with the external environment and the largest area exposed in the air, so that environmental air pollution is an important risk factor for skin diseases.
Environmental pollution can cause a series of problems to skin, and related researches find that the environmental pollution can cause the problems of atopic dermatitis, eczema, urticaria, skin aging, skin color spots and the like. In addition to improving the environment, for example by reducing the emission of fine particles in the air, personal protection, for example by skin care products, can also be enhanced to eliminate or reduce the risk of pollutants on the skin.
Patent CN103735458B discloses a skin anti-allergy repairing composition, which comprises, by weight: 5 to 12 percent of humectant, 0.1 to 3.0 percent of thickening agent, 1 to 4 percent of skin repairing agent, 0.1 to 1.5 percent of preservative and the balance of water. The anti-allergy skin repair composition has strong effects of clearing heat, removing toxicity, anti-allergy repair, diminishing inflammation, astringing and the like; the other auxiliary additive components are selected from moisturizers, preservatives, thickeners and the like which can make the skin tender, smooth and moist and are mild and non-irritant to the skin, are convenient to use, achieve the purposes of moisturizing, diminishing inflammation, relieving itching and repairing damaged skin, and are suitable for sensitive skin and the phenomena of skin allergy, pruritus, desquamation, redness and the like caused by improper use of cosmetics. However, the existing skin care compositions mainly aim at people who suffer from environmental pollution and generate sensitive skin, and are not compositions for preventing environmental pollution.
Therefore, in the field of skin care products, there is a strong need for a skin care composition that can protect the skin from environmental pollution, improve the self-healing ability of the skin, and allow the skin to self-heal in a healthier environment.
Disclosure of Invention
In view of this, the present invention aims to provide a skin care composition for resisting environmental pollution and improving the self-healing ability of skin, which has a good skin-healing effect.
Therefore, the invention provides the following technical scheme.
In a first aspect, the present invention provides a skin care composition, wherein the composition comprises: VP/hexadecene copolymer, polyquaternium-7, moringa pterospolia seed extract, nicotinamide and Saccharomyces bifidus fermentation product lysate.
In a preferred embodiment, the composition further comprises: emulsifiers, humectants, antioxidants and preservatives;
wherein,
the emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, polysorbate-20, PEG-100 distearate, sorbitan olivil oleate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the humectant is selected from one or more of glycerol, diglycerol, propylene glycol, 1, 3-butylene glycol, 1, 2-pentanediol, polyethylene glycol-8, polyethylene glycol-32, glyceryl polyether-7, sodium hyaluronate, glyceryl polyether-26, glyceryl glucoside, sucrose, rhamnose, mannose, raffinose, betaine, erythritol, xylitol, biogum-2, urea, glyceryl polyether-5 lactate, sodium polyglutamate, hydrolyzed sclerotium rolfsii gum, pullulan, tremella polysaccharide and sour bean seed polysaccharide;
the antioxidant is selected from one or more of tocopherol, tert-butyl hydroxy cumin, tert-butyl hydroxy toluene and propyl gallate;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
In a more preferred embodiment, the composition may further comprise water.
In a preferred embodiment, wherein, in parts by weight, the composition comprises:
0.2 to 3 parts of VP hexadecene copolymer, for example, the parts by weight of VP hexadecene copolymer may be 0.2, 0.3, 0.4, 0.5, 0.7, 1, 1.2, 1.3, 1.5, 1.7, 2, 2.3, 2.5, 2.7, 2.9 or 3;
0.2 to 2 parts of polyquaternium-7, for example, the weight part of polyquaternium-7 may be 0.2, 0.3, 0.4, 0.5, 0.7, 1, 1.2, 1.3, 1.5, 1.7 or 2;
0.1-3 parts of winged seed moringa seed extract, for example, the parts by weight of the winged seed moringa seed extract can be 0.1, 0.2, 0.3, 0.4, 0.5, 0.7, 1, 1.2, 1.3, 1.5, 1.7, 2, 2.3, 2.5, 2.7, 2.9, or 3;
0.5-5 parts of nicotinamide; for example, the weight fraction of nicotinamide can be 0.5, 0.7, 1, 1.2, 1.3, 1.5, 1.7, 2, 2.3, 2.5, 2.7, 2.9, 3, 3.1, 3.3, 3.5, 3.7, 4, 4.1, 4.3, 4.5, 4.7, or 5;
and 0.5-10 parts of a split yeast fermentation product lysate, for example, the weight parts of the split yeast fermentation product lysate can be 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, or 10.
In a preferred embodiment, wherein, according to parts by weight, the composition further comprises:
0.2 to 3 parts of emulsifier, for example, the parts by weight of emulsifier may be 0.2, 0.3, 0.5, 0.7, 1, 1.3, 1.5, 1.7, 2, 2.1, 2.3, 2.5, 2.7 or 3;
1-8 parts of humectant, for example, the humectant can be 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, or 8 parts by weight;
0.05 to 0.3 parts of antioxidant, for example, the parts by weight of said antioxidant may be 0.05, 0.07, 0.1, 0.15, 0.2, 0.25 or 0.3;
and 0.3 to 0.7 parts preservative, for example, the preservative may be present in an amount of 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65 or 0.7 parts by weight.
In a second aspect, the present invention provides a skin care composition, wherein the composition comprises, in parts by weight: 0.2-3 parts of VP/hexadecene copolymer, 0.2-2 parts of polyquaternary ammonium salt-7, 0.1-3 parts of winged seed moringa seed extract, 0.5-5 parts of nicotinamide, 0.5-10 parts of schizosaccharomyces cerevisiae fermentation product lysate, 0.2-3 parts of emulsifier, 1-8 parts of humectant, 0.05-0.3 part of antioxidant and 0.3-0.7 part of preservative;
wherein,
the emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, polysorbate-20, PEG-100 distearate, sorbitan olivil oleate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the humectant is selected from one or more of glycerol, diglycerol, propylene glycol, 1, 3-butanediol, 1, 2-pentanediol, polyethylene glycol-8, polyethylene glycol-32, glyceryl polyether-7, sodium hyaluronate, glyceryl polyether-26, glyceryl glucoside, sucrose, rhamnose, mannose, raffinose, betaine, erythritol, xylitol, biogum-2, urea, glyceryl polyether-5 lactate, sodium polyglutamate, hydrolyzed sclerotium rolfsii gum, pullulan, tremella polysaccharide and sour bean seed polysaccharide;
the antioxidant is selected from one or more of tocopherol, tert-butyl hydroxy cumin, tert-butyl hydroxy toluene and propyl gallate;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
In a third aspect, the present invention provides a skin care composition, wherein the composition comprises, in parts by weight: 1 part of VP/hexadecene copolymer, 0.5 part of polyquaternium-7, 2 parts of moringa pterocarpa seed extract, 3 parts of nicotinamide, 5 parts of schizosaccharomyces cerevisiae fermentation product lysate, 2.5 parts of emulsifier, 6 parts of humectant, 0.1 part of antioxidant and 0.4 part of preservative;
wherein,
the emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, polysorbate-20, PEG-100 distearate, sorbitan olivil oleate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the humectant is selected from one or more of glycerol, diglycerol, propylene glycol, 1, 3-butanediol, 1, 2-pentanediol, polyethylene glycol-8, polyethylene glycol-32, glyceryl polyether-7, sodium hyaluronate, glyceryl polyether-26, glyceryl glucoside, sucrose, rhamnose, mannose, raffinose, betaine, erythritol, xylitol, biogum-2, urea, glyceryl polyether-5 lactate, sodium polyglutamate, hydrolyzed sclerotium rolfsii gum, pullulan, tremella polysaccharide and sour bean seed polysaccharide;
the antioxidant is selected from one or more of tocopherol, tert-butyl hydroxy cumin, tert-butyl hydroxy toluene and propyl gallate;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glycerol caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glycerol caprylate.
In a fourth aspect, the present disclosure provides a method for preparing a skin care composition, wherein the method comprises the steps of:
1) Mixing humectant, polyquaternium-7, emulsifier and water, heating to 80-85 deg.C, stirring to dissolve;
2) Dissolving VP/hexadecene copolymer and antioxidant in the material obtained in step one, mixing and heating to 80-85 deg.C, stirring to dissolve, and homogenizing;
3) Emulsifying the material obtained in the second step in a container, adding the lysate of the fermentation product of the second split yeast, the extract of the moringa oleifera seeds, nicotinamide and the preservative when the temperature is reduced to 40-45 ℃, and uniformly stirring.
In a preferred embodiment, the skin care composition is a composition according to the present invention.
In a preferred embodiment of the present invention,
the emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate and polysorbate-20;
the humectant is selected from one or more of sodium hyaluronate, glyceryl polyether-26 and sucrose;
the antioxidant is selected from one or more of tocopherol, tert-butyl hydroxy cumin and propyl gallate;
the preservative is selected from one or more of methylparaben, propylparaben and phenoxyethanol.
In a fifth aspect, a skin care product is provided, the skin care product comprising the skin care composition of the present invention.
In a sixth aspect, a pharmaceutical composition is provided comprising a safe and effective amount of a skin care composition according to the present invention.
In addition, the invention also provides the application of the skin care composition in preparing a skin care product or a pharmaceutical composition.
In the present invention, a split yeast fermentation product lysate is available ex situ, for example from Chemisches laboratories dr. Kurt Richter Gmbh, batch No. 3191570; moringa oleifera seed extract is commercially available, for example from basf, inc. under batch number 0018879081; the VP/hexadecene copolymer is commercially available, for example, from the Ashland group corporation under the batch number 0002186930.
In the present invention, the emulsifier can improve the surface tension between various constituent phases in the emulsion, so that the emulsion forms a uniform and stable dispersion system or a substance of the emulsion; emulsifiers are surface-active substances which have both hydrophilic and lipophilic groups in the molecule and which accumulate at the oil/water interface and reduce the interfacial tension and the energy required to form an emulsion, thereby increasing the energy of the emulsion.
In the present invention, moisturizers are water-soluble substances that increase skin moisture or reduce the transdermal water loss of the skin.
In the present invention, the antioxidant is a substance that prevents the adverse effect of oxygen; it can prevent or delay the oxidation of skin care products, and is a skin care product additive for improving the stability of the skin care products and prolonging the storage period.
In the present invention, the preservative means a substance added to the skin care composition for the purpose of inhibiting the growth and proliferation of microorganisms in the skin care composition, and is used to prolong the shelf life of the skin care composition.
In the present invention, the skin care product may include a container, instructions for use, use aids, and/or other structures and/or agents as desired for performing the performance test; adjuvants used in the skin care products of the present invention include, but are not limited to, oils, emulsifiers, humectants, thickeners, skin conditioning agents, and/or preservatives; other structures necessary for performing performance tests in the skin care products of the present invention include, but are not limited to, structures for sampling, structures for performing control, and/or structures for observing the assay process or results; the other agents required for performing performance tests in the skin care products of the present invention include, but are not limited to, culture media, detergents, developers, and/or terminators.
In the invention, the pharmaceutical composition comprises the skin care composition and pharmaceutically acceptable auxiliary materials.
In the present invention, a safe and effective amount refers to an amount of a compound or composition sufficient to significantly induce a positive benefit, preferably a positive skin tissue appearance or feel benefit, including the benefits disclosed herein, either individually or in combination, but low enough to avoid serious side effects, i.e., to provide a reasonable benefit to risk ratio, within the scope of sound judgment of the skilled artisan.
Compared with the prior art, the invention has the beneficial effects that:
the skin care composition disclosed by the invention can isolate skin from external environment pollutants in a film forming mode, and the oil-soluble film forming agent VP/hexadecene copolymer is introduced, so that a layer of soft, compact and continuous covering film can be formed on the surface of the skin after the skin care composition is applied, and the covering film has water locking capacity, so that the skin can generate smooth feeling; the polyquaternium-7 which is a water-soluble film forming agent is an effective smoothing and lubricating wetting agent, can generate a smooth residual film which is not sticky and greasy on the skin, can form a water-soluble film and prevents pollution; the environmental pollution is resisted by constructing a skin defense wall; a specific humectant is introduced, so that the skin can be pacified, and the skin can reach the optimal moisturizing state; the specific antioxidant is introduced to resist free radicals, inhibit the generation of lipid peroxide, eliminate excessive oxygen free radicals caused by external factors such as ultraviolet rays and air pollution, and play a role in delaying photoaging, preventing sunburn and inhibiting the generation of sunburn erythema; the moringa oleifera seed extract is matched, so that the free radicals are eliminated, the water can be supplemented, and the effect of moisturizing is achieved; by matching with the nicotinamide disclosed by the invention, the water loss through the skin is reduced, the sebum secretion is reduced, the barrier function of the skin is enhanced, the cohesiveness and the thickness of the stratum corneum are increased, and the maturity of the stratum corneum is increased; the yeast lysate of the yeast for bifida of the invention is matched to repair DNA damaged by light pollution and environmental pollution, keep IL-10/IL12 balance, initiate skin repair, help epidermal cells and dermal cells in skin to resist harmful effects of light pollution, maintain the integrity and vitality of cells, and enable skin to carry out self-repair in a relatively healthy environment.
The skin care composition simultaneously protects and repairs the skin through physical action and chemical action, so that the skin can obtain double modes in a polluted environment, and the influence of pollutants on the skin is isolated by adding the oil-soluble and water-soluble physical film forming agent externally; the antioxidant is added into the medicine to resist the invasion of free radicals; meanwhile, a repair component is added to repair the damaged area.
By screening the types of the components in the skin care composition and adjusting the content of the components in the skin care composition, the skin care composition has stronger environmental pollution resistance and stronger self-repairing capability, and the skin has better repairing effect.
On the other hand, the skin care composition has simple production process and low cost.
Detailed Description
The present invention will be specifically explained below with reference to specific embodiments and examples, and the advantages and various effects of the present invention will be more clearly demonstrated. It will be understood by those skilled in the art that these specific embodiments and examples are illustrative of the invention and are not to be construed as limiting the invention.
Example 1
This example provides a skin care composition, comprising, in parts by weight:
0.2 parts of VP/hexadecene copolymer, 0.2 parts of polyquaternium-7, 0.1 parts of Moringa pterospifolia seed extract, 0.5 parts of nicotinamide, 0.5 parts of schizosaccharomyces cerevisiae fermentation product lysate, 0.2 parts of PEG-20 methyl glucose sesquistearate, 1 part of glyceryl polyether-26, 0.1 parts of sodium hyaluronate, 0.05 parts of tocopherol, 0.3 parts of methylparaben and an appropriate amount of water.
The skin care composition of this example was prepared as follows:
1) Mixing 1 part of glyceryl polyether-26, 0.1 part of sodium hyaluronate, 0.2 part of polyquaternium-7, 0.2 part of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 80 ℃, and stirring to dissolve;
2) Dissolving 0.2 part of VP/hexadecene copolymer and 0.05 part of tocopherol in the material obtained in the first step, mixing and heating to 80 ℃, stirring to dissolve and homogenize the mixture;
3) Emulsifying the material obtained in the second step in a container, adding 0.5 part of schizosaccharomyces cerevisiae fermentation product lysate, 0.1 part of moringa oleifera seed extract, 0.5 part of nicotinamide and 0.3 part of methylparaben when the temperature is reduced to 40 ℃, and uniformly stirring.
Example 2
This example provides a skin care composition comprising, in parts by weight:
3 parts of VP/hexadecene copolymer, 2 parts of polyquaternium-7, 3 parts of moringa oleifera seed extract, 5 parts of nicotinamide, 10 parts of schizosaccharomyces cerevisiae fermentation product lysate, 3 parts of PEG-20 methyl glucose sesquistearate, 8 parts of glyceryl polyether-26, 0.5 part of sodium hyaluronate, 0.3 part of tocopherol, 0.7 part of methylparaben and a proper amount of water.
The skin care composition of this example was prepared as follows:
1) Mixing 8 parts of glyceryl polyether-26, 0.5 part of sodium hyaluronate, 2 parts of polyquaternium-7, 3 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve;
2) Dissolving 3 parts of VP/hexadecene copolymer and 0.3 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 10 parts of the yeast schizolysis product, 3 parts of the moringa oleifera seed extract, 5 parts of nicotinamide and 0.7 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
Example 3
This example provides a skin care composition comprising, in parts by weight:
1 part of VP/hexadecene copolymer, 0.5 part of polyquaternium-7, 2 parts of moringa pterocarpa seed extract, 3 parts of nicotinamide, 5 parts of schizosaccharomyces cerevisiae fermentation product lysate, 2.5 parts of PEG-20 methyl glucose sesquistearate, 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.1 part of tocopherol, 0.4 part of methylparaben and a proper amount of water.
The skin care composition of this example was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the yeast schizolysis product, 2 parts of the moringa oleifera seed extract, 3 parts of nicotinamide and 0.4 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 1
To further illustrate the beneficial effects of the present invention, comparative example 1 is provided, which is different from example 3 in that: the glyceryl polyether-26 of the present invention was replaced with methyl gluceth-10.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of methyl glucitol polyether-10, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve the mixture;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the schizosaccharomyces cerevisiae fermentation product lysate, 2 parts of the pterospermum pterocarpum seed extract, 3 parts of nicotinamide and 0.4 part of methylparaben when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 2
To further illustrate the beneficial effects of the present invention, comparative example 2 is provided, which comparative example 2 differs from example 3 in that: PEG-20 methyl glucose sesquistearate of the present invention is replaced with glycerol stearate.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of glyceryl stearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the schizosaccharomyces cerevisiae fermentation product lysate, 2 parts of the pterospermum pterocarpum seed extract, 3 parts of nicotinamide and 0.4 part of methylparaben when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 3
To further illustrate the beneficial effects of the present invention, comparative example 3 is provided, which comparative example 3 differs from example 3 in that: the tocopherol of the present invention was replaced with catalase.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve the mixture;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of catalase in the material obtained in the step one, mixing and heating to 85 ℃, stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the yeast schizolysis product, 2 parts of the moringa oleifera seed extract, 3 parts of nicotinamide and 0.4 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 4
To further illustrate the beneficial effects of the present invention, comparative example 4 is provided, which comparative example 4 differs from example 3 in that: the methylparaben of the present invention is replaced with salicylic acid.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve the mixture;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of schizosaccharomyces cerevisiae fermentation product lysate, 2 parts of pterospermum pterocarpum seed extract, 3 parts of nicotinamide and 0.4 part of salicylic acid when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 5
To further illustrate the beneficial effects of the present invention, comparative example 5 is provided, which comparative example 5 differs from example 3 in that: no VP hexadecene copolymer was added.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve;
2) Dissolving 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the yeast schizolysis product, 2 parts of the moringa oleifera seed extract, 3 parts of nicotinamide and 0.4 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 6
To further illustrate the beneficial effects of the present invention, comparative example 6 is provided, which comparative example 6 differs from example 3 in that: no polyquaternium-7 was added.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the yeast schizolysis product, 2 parts of the moringa oleifera seed extract, 3 parts of nicotinamide and 0.4 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 7
To further illustrate the beneficial effects of the present invention, comparative example 7 is provided, which comparative example 7 differs from example 3 in that: no Moringa oleifera seed extract was added.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the yeast schizolysis product, 3 parts of nicotinamide and 0.4 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 8
To further illustrate the beneficial effects of the present invention, comparative example 8 is provided, which comparative example 8 differs from example 3 in that: no niacinamide was added.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve the mixture;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the step two in a container, adding 5 parts of the schizosaccharomyces cerevisiae fermentation product lysate, 2 parts of the pterospermum pterocarpum seed extract and 0.4 part of methylparaben when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 9
To further illustrate the beneficial effects of the present invention, comparative example 9 is provided, which comparative example 9 differs from example 3 in that: no addition of the yeast two split fermentation product lysate.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve the mixture;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) Emulsifying the material obtained in the second step in a container, adding 2 parts of winged seed moringa seed extract, 3 parts of nicotinamide and 0.4 part of methylparaben when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 10
To further illustrate the beneficial effects of the present invention, comparative example 10 is provided, which comparative example 10 differs from example 3 in that: polyquaternium-7 and winged seed Moringa seed extract were not added.
The comparative skin care composition was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the yeast schizolysis product, 3 parts of nicotinamide and 0.4 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 11
To further illustrate the beneficial effects of the present invention, comparative example 11 is provided, which comparative example 11 differs from example 3 in that: nicotinamide and yeast lysate were not added.
The skin care composition of this example was prepared as follows:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve the mixture;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, stirring to dissolve and homogenize the mixture;
3) Emulsifying the material obtained in the second step in a container, adding 2 parts of the winged seed moringa oleifera seed extract and 0.4 part of methylparaben when the temperature is reduced to 45 ℃, and uniformly stirring.
Comparative example 12
To further illustrate the benefits of the present invention, a skin anti-allergy rejuvenating composition is provided, which is prepared using the method of patent CN 103735458B.
Experiment 1: effect verification
And (3) testing a sample: the present specification describes the samples prepared in examples 1 to 3 and comparative examples 1 to 12.
The experimental method comprises the following steps: 150 volunteers with a large number of pollutants in their environment were selected, wherein the age distribution was 15-60 years, and randomly divided into fifteen groups, A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, 10 people per group. Wherein group A applied the skin care composition prepared in example 1 above according to the present invention,
group B applied the skin care composition prepared by the above example 2 of the present invention,
group C applied the skin care composition prepared by the above example 3 of the present invention,
group D applied the skin care composition prepared from comparative example 1,
group E applied the skin care composition prepared from comparative example 2,
group F applied the skin care composition prepared from comparative example 3,
group G applied the skin care composition prepared from comparative example 4,
group H applied the skin care composition prepared from comparative example 5,
group I applied the skin care composition prepared from comparative example 6,
group J applied the skin care composition prepared from comparative example 7,
group K applied the skin care composition prepared from comparative example 8,
group L applied the skin care composition prepared from comparative example 9,
group M applied the skin care composition prepared from comparative example 10,
n groups applied the skin care composition prepared from comparative example 11,
group O applied the skin anti-allergy repair composition prepared by comparative example 12.
The preparation is administered once a day, and 10 days later. The evaluation score was 10 points, and the test evaluation results are shown in table 1 below.
TABLE 1
From the above results, it can be seen that:
after the skin care composition provided by the invention is continuously used, pores are reduced, a volunteer reflects that the skin care composition has strong film forming feeling, the skin surface can feel the film forming feeling, the oil secretion of the skin is obviously reduced, the skin inflammation is relieved, and the volunteer can feel good permeability and moisture retention after applying the skin care composition, and has no irritation. The skin care composition disclosed by the invention can relieve the pollution resistance problem of the skin, has the effect of repairing skin injury and has a better skin repairing effect. The skin care composition without the skin care composition has certain anti-inflammatory repair effect, but the anti-environmental pollution effect and the film forming property are obviously poor.
Experiment 2: patch test and allergy test on human skin
And (3) testing a sample: the present specification describes the samples prepared in examples 1 to 3 and comparative examples 1 to 12.
The experimental method comprises the following steps: 90 subjects were selected, with an age distribution of 15-60 years, and randomized into fifteen groups of 6 people each. Wherein, marking a 5cm multiplied by 5cm area of the right forearm of the subject on the flexed side, disinfecting the marked area by using 75% alcohol, and creating the wound by the method: introducing 36-needle micro needles for 30s by using nutrient solution and factors, lightly wiping residual liquid by using a cotton ball soaked by normal saline, and keeping a marked area dry; the spot tester is numbered 0-15, the tested samples are respectively put into the spot tester cells No. 1-15, the dosage is 0.020-0.025g, the subjects are asked to feel, the bathing is prohibited during the tested period, and the normal reaction is negative.
The test sample is delivered to the subject, and acts on the face, neck and back of the ear of the subject, and the skin state of the subject is observed after 10min, and the experimental results are shown in the following table 2.
TABLE 2
From the above results, it can be seen that:
the spot sticking reaction of the skin care composition is a negative reaction, so that the safety is high; moreover, after the skin care composition of the invention acts on the face, the neck and the back of the ear of a subject, no anaphylactic reaction exists, which shows that the anti-anaphylactic effect of the skin care composition of the invention is better. When the skin care composition of the invention is not used, slight anaphylactic reaction can be seen after the skin care composition is acted on the face and the neck of a subject, which indicates that the anti-allergic effect is poor.
It is to be understood that the invention disclosed is not limited to the particular methodology, protocols, and materials described, as these may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention which will be limited only by the appended claims.
Those skilled in the art will also recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.
Claims (3)
1. A skin care composition comprises, in combination,
the composition comprises the following components in parts by weight:
1 part of VP/hexadecene copolymer, 0.5 part of polyquaternium-7, 2 parts of moringa pterocarpa seed extract, 3 parts of nicotinamide, 5 parts of schizosaccharomyces cerevisiae fermentation product lysate, 2.5 parts of PEG-20 methyl glucose sesquistearate, 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.1 part of tocopherol, 0.4 part of methylparaben and a proper amount of water;
the skin care composition is prepared by the following steps:
1) Mixing 6 parts of glyceryl polyether-26, 0.3 part of sodium hyaluronate, 0.5 part of polyquaternium-7, 2.5 parts of PEG-20 methyl glucose sesquistearate and a proper amount of water, heating to 85 ℃, and stirring to dissolve the mixture;
2) Dissolving 1 part of VP/hexadecene copolymer and 0.1 part of tocopherol in the material obtained in the step one, mixing and heating to 85 ℃, and stirring to dissolve and homogenize the mixture;
3) And (3) emulsifying the material obtained in the second step in a container, adding 5 parts of the yeast schizolysis product, 2 parts of the moringa oleifera seed extract, 3 parts of nicotinamide and 0.4 part of methyl hydroxybenzoate when the temperature is reduced to 45 ℃, and uniformly stirring.
2. A skin care product, wherein said skin care product comprises the skin care composition of claim 1.
3. Use of the skin care composition of claim 1 in the preparation of a skin care product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910630710.5A CN112206187B (en) | 2019-07-12 | 2019-07-12 | Skin care compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910630710.5A CN112206187B (en) | 2019-07-12 | 2019-07-12 | Skin care compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112206187A CN112206187A (en) | 2021-01-12 |
CN112206187B true CN112206187B (en) | 2023-03-03 |
Family
ID=74047836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910630710.5A Active CN112206187B (en) | 2019-07-12 | 2019-07-12 | Skin care compositions |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112206187B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115444772B (en) * | 2022-10-26 | 2023-07-14 | 广州艾卓生物科技股份有限公司 | Moisturizing and whitening composition and application thereof in radio frequency beauty and medical skin care |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012232915A (en) * | 2011-04-28 | 2012-11-29 | Ivy Cosmetics Corp | Skin care preparation for antiaging |
CN104921978A (en) * | 2014-03-10 | 2015-09-23 | 玫琳凯有限公司 | Skin Lightening Compositions |
CN106606453A (en) * | 2017-01-11 | 2017-05-03 | 杭州菲丝凯化妆品有限公司 | Moisture-retaining anti-acne cream and preparation method thereof |
CN107095842A (en) * | 2017-05-04 | 2017-08-29 | 广州诺胜化妆品有限公司 | A kind of moringa seeds elite antipollution facial mask and preparation technology |
CN108125803A (en) * | 2018-02-07 | 2018-06-08 | 中国科学院化学研究所 | A kind of whitening spot-eliminating composition |
CN108478459A (en) * | 2018-04-28 | 2018-09-04 | 广东巴松那生物科技有限公司 | A kind of eye essence of the lysate containing lactobacillus fermentation and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060275247A1 (en) * | 2005-06-01 | 2006-12-07 | Revlon Consumer Products Corporation | Cosmetic Compositions With Moringa Seed Extract |
-
2019
- 2019-07-12 CN CN201910630710.5A patent/CN112206187B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012232915A (en) * | 2011-04-28 | 2012-11-29 | Ivy Cosmetics Corp | Skin care preparation for antiaging |
CN104921978A (en) * | 2014-03-10 | 2015-09-23 | 玫琳凯有限公司 | Skin Lightening Compositions |
CN106606453A (en) * | 2017-01-11 | 2017-05-03 | 杭州菲丝凯化妆品有限公司 | Moisture-retaining anti-acne cream and preparation method thereof |
CN107095842A (en) * | 2017-05-04 | 2017-08-29 | 广州诺胜化妆品有限公司 | A kind of moringa seeds elite antipollution facial mask and preparation technology |
CN108125803A (en) * | 2018-02-07 | 2018-06-08 | 中国科学院化学研究所 | A kind of whitening spot-eliminating composition |
CN108478459A (en) * | 2018-04-28 | 2018-09-04 | 广东巴松那生物科技有限公司 | A kind of eye essence of the lysate containing lactobacillus fermentation and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112206187A (en) | 2021-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109846757B (en) | Sebum biomimetic composition and cosmetic containing same | |
CN111956591B (en) | Anti-allergy, soothing and skin color improving cosmetic composition and preparation method thereof | |
JP4116243B2 (en) | Skin composition | |
CN110279638A (en) | A kind of reparation skin skin care compositions and preparation method thereof | |
CN110731923A (en) | Enhanced moisturizing cosmetic compositions | |
KR102310170B1 (en) | cosmetic composition for improving skin condition and manufacturing method thereof | |
KR101500191B1 (en) | Skin care compositions and method for manufacturing the same | |
CN113116755A (en) | Skin care composition for promoting penetration and preparation method and application thereof | |
CN111067828A (en) | Cosmetic composition for anti-allergy repair | |
CN113244141A (en) | Essence cream for repairing skin barrier function and preparation method thereof | |
CN111973509A (en) | Skin care composition containing plant extract for soothing allergy | |
CN116327636A (en) | Moisturizing repair composition, application and preparation method thereof | |
CN112206187B (en) | Skin care compositions | |
CN112121002B (en) | Moisturizing and repairing composition and cosmetic | |
CN112716849A (en) | Anti-chap skin cream containing camellia oleifera extract | |
CN108771643A (en) | It is full of and moistens maintenance essence | |
CN111973471A (en) | Cosmetic composition | |
CN117257695A (en) | Fermented water-oil double-layer composition and preparation method and application thereof | |
KR100827244B1 (en) | Nourishing cream composition for keeping moisture of skin with capability of emitting far infrared ray | |
CN115607479A (en) | Moisturizing composition and moisturizing liquid for skin | |
KR102333132B1 (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil | |
KR20140018443A (en) | Composition containing fermenting lactobacillus for protection and treatment of skin diseases | |
CN110496065A (en) | Moisturizing composition | |
CN112402335A (en) | Water-bursting powder and preparation method thereof | |
CN110236986B (en) | Moisturizing lotion with refreshing and moistening functions and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |